A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
A Study to Investigate Gastrointestinal Epithelial Integrity and Arterial Inflammation in Individuals With and Without HIV
Sponsor: Massachusetts General Hospital
Listed as NCT02431325, this PHASE2 trial focuses on HIV and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 9 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2021 — Jul 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE2
▶ Show 4 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
-
Jul 2019 — Dec 2019 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- Ragon Institute of MGH, MIT and Harvard
For direct contact, visit the study record on ClinicalTrials.gov .